Dr. Frans Berend Mensink, Dr. Dirk-Jan van Genus and Dr. C Michael Gibson Discuss: Functional Improvement of non-infarcT relaTed coronary artery stenosis by Extensive LDL-C Reduction with a PCSK9 Antibody September 1, 2024 Disclosures: TBD
Dr. Gi-Byoung Nam, Dr. Dukwoo Park and Dr. C Michael Gibson Discuss: EPIC-CAD – Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary artery disease September 1, 2024 Disclosures: TBD
Dr. Rabea Asleh and Dr. C Michael Gibson Discuss: Gut Microbiota and Associated Metabolites Play a Key Role in the Pathogenesis of the Obesity Phenotype of Heart Failure With Preserved Ejection Fraction September 1, 2024 Disclosures: TBD
Dr. Manesh Patel and Dr. C Michael Gibson Discuss: OCEANIC-AF – Asundexian versus apixaban in patients with atrial fibrillation September 1, 2024
Dr. Dipak Kotecha and Dr. C Michael Gibson Discuss: STEEER-AF – Stroke prevention and rhythm control therapy September 1, 2024 Disclosures: TBD
